Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Management of Lower Gastrointestinal Bleeding

Initial Assessment and Risk Stratification

  • Patients with lower gastrointestinal bleeding and an Oakland score >8 points should be hospitalized for management, while those with a score ≤8 points can be safely discharged for outpatient investigation 1, 2, 3
  • The Oakland score is a validated risk assessment tool that includes components such as age, gender, previous LGIB admission, digital rectal examination findings, heart rate, systolic blood pressure, and hemoglobin level 2
  • The American Gastroenterological Association recommends using the Oakland score to determine the need for hospitalization in patients with lower gastrointestinal bleeding 1, 3
  • The score has a high predictive accuracy (AUROC 0.85-0.87) for identifying patients who can be safely discharged 1, 3

Management Algorithm

  • Hemodynamically stable patients with lower gastrointestinal bleeding should have their Oakland score calculated to determine the need for hospitalization 1, 3
  • Patients with a score ≤8 points are characterized by the absence of rebleeding, need for transfusion, therapeutic intervention, in-hospital death, and readmission within 28 days, and should have urgent outpatient colonoscopy (within 2 weeks if high-risk features present) 2, 3
  • Patients with a score >8 points require hospital admission and should undergo inpatient colonoscopy on the next available list 1, 3, 5

Considerations and Caveats

  • The Oakland score may perform differently in populations outside of the UK, where it was developed 3
  • The score may underestimate the number of patients who can be safely discharged due to liberal use of blood transfusions in the derivation population 3
  • Initial assessment should always include digital rectal examination to assess for anorectal causes, which account for approximately 16.7% of LGIB diagnoses 2